-
Je něco špatně v tomto záznamu ?
4-Methylumbeliferone Treatment at a Dose of 1.2 g/kg/Day Is Safe for Long-Term Usage in Rats
K. Štěpánková, D. Mareková, K. Kubášová, R. Sedláček, K. Turnovcová, I. Vacková, Š. Kubinová, P. Makovický, M. Petrovičová, JCF. Kwok, P. Jendelová, L. Machová Urdzíková
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
MC-PC-16050
Medical Research Council - United Kingdom
MR/S011110/1
Medical Research Council - United Kingdom
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
PubMed Central
od 2007
Europe PubMed Central
od 2007
ProQuest Central
od 2000-03-01
Open Access Digital Library
od 2000-01-01
Open Access Digital Library
od 2007-01-01
Health & Medicine (ProQuest)
od 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
PubMed
36835210
DOI
10.3390/ijms24043799
Knihovny.cz E-zdroje
- MeSH
- hymekromon * škodlivé účinky terapeutické užití MeSH
- interleukin-12 MeSH
- krysa rodu rattus MeSH
- kyselina hyaluronová * metabolismus MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
4-methylumbelliferone (4MU) has been suggested as a potential therapeutic agent for a wide range of neurological diseases. The current study aimed to evaluate the physiological changes and potential side effects after 10 weeks of 4MU treatment at a dose of 1.2 g/kg/day in healthy rats, and after 2 months of a wash-out period. Our findings revealed downregulation of hyaluronan (HA) and chondroitin sulphate proteoglycans throughout the body, significantly increased bile acids in blood samples in weeks 4 and 7 of the 4MU treatment, as well as increased blood sugars and proteins a few weeks after 4MU administration, and significantly increased interleukins IL10, IL12p70 and IFN gamma after 10 weeks of 4MU treatment. These effects, however, were reversed and no significant difference was observed between control treated and 4MU-treated animals after a 9-week wash-out period.
Department of Biology Faculty of Education J Seyle University SK 94501 Komarno Slovakia
Department of Neuroscience 2nd Faculty of Medicine Charles University 15006 Prague Czech Republic
Institute of Experimental Medicine Czech Academy of Sciences 14220 Prague Czech Republic
Institute of Physics Czech Academy of Sciences 18221 Prague Czech Republic
Institute of Physiology Czech Academy of Sciences 14220 Prague Czech Republic
School of Biomedical Sciences Faculty of Biological Sciences University of Leeds Leeds LS2 9JT UK
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23004174
- 003
- CZ-PrNML
- 005
- 20230425141135.0
- 007
- ta
- 008
- 230418s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms24043799 $2 doi
- 035 __
- $a (PubMed)36835210
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Štěpánková, Kateřina $u Institute of Experimental Medicine, Czech Academy of Sciences, 14220 Prague, Czech Republic $u Department of Neuroscience, Second Faculty of Medicine, Charles University, 15006 Prague, Czech Republic $1 https://orcid.org/0000000327848434
- 245 10
- $a 4-Methylumbeliferone Treatment at a Dose of 1.2 g/kg/Day Is Safe for Long-Term Usage in Rats / $c K. Štěpánková, D. Mareková, K. Kubášová, R. Sedláček, K. Turnovcová, I. Vacková, Š. Kubinová, P. Makovický, M. Petrovičová, JCF. Kwok, P. Jendelová, L. Machová Urdzíková
- 520 9_
- $a 4-methylumbelliferone (4MU) has been suggested as a potential therapeutic agent for a wide range of neurological diseases. The current study aimed to evaluate the physiological changes and potential side effects after 10 weeks of 4MU treatment at a dose of 1.2 g/kg/day in healthy rats, and after 2 months of a wash-out period. Our findings revealed downregulation of hyaluronan (HA) and chondroitin sulphate proteoglycans throughout the body, significantly increased bile acids in blood samples in weeks 4 and 7 of the 4MU treatment, as well as increased blood sugars and proteins a few weeks after 4MU administration, and significantly increased interleukins IL10, IL12p70 and IFN gamma after 10 weeks of 4MU treatment. These effects, however, were reversed and no significant difference was observed between control treated and 4MU-treated animals after a 9-week wash-out period.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 12
- $a kyselina hyaluronová $x metabolismus $7 D006820
- 650 12
- $a hymekromon $x škodlivé účinky $x terapeutické užití $7 D006923
- 650 _2
- $a interleukin-12 $7 D018664
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Mareková, Dana $u Institute of Experimental Medicine, Czech Academy of Sciences, 14220 Prague, Czech Republic $u Department of Neuroscience, Second Faculty of Medicine, Charles University, 15006 Prague, Czech Republic
- 700 1_
- $a Kubášová, Kristýna $u Department of Mechanics, Biomechanics and Mechatronics, Faculty of Mechanical Engineering, Czech Technical University in Prague, 16000 Prague, Czech Republic $1 https://orcid.org/0000000298924281
- 700 1_
- $a Sedláček, Radek $u Department of Mechanics, Biomechanics and Mechatronics, Faculty of Mechanical Engineering, Czech Technical University in Prague, 16000 Prague, Czech Republic $1 https://orcid.org/0000000184685921 $7 ntka173960
- 700 1_
- $a Turnovcová, Karolína $u Institute of Experimental Medicine, Czech Academy of Sciences, 14220 Prague, Czech Republic
- 700 1_
- $a Vacková, Irena $u Institute of Experimental Medicine, Czech Academy of Sciences, 14220 Prague, Czech Republic $u Institute of Physiology, Czech Academy of Sciences, 14220 Prague, Czech Republic
- 700 1_
- $a Kubinová, Šárka $u Institute of Experimental Medicine, Czech Academy of Sciences, 14220 Prague, Czech Republic $u Institute of Physics, Czech Academy of Sciences, 18221 Prague, Czech Republic
- 700 1_
- $a Makovický, Pavol $u Department of Biology, Faculty of Education, J. Seyle University, SK-94501 Komarno, Slovakia
- 700 1_
- $a Petrovičová, Michaela $u Institute of Experimental Medicine, Czech Academy of Sciences, 14220 Prague, Czech Republic
- 700 1_
- $a Kwok, Jessica C F $u Institute of Experimental Medicine, Czech Academy of Sciences, 14220 Prague, Czech Republic $u School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK $1 https://orcid.org/0000000297989083
- 700 1_
- $a Jendelová, Pavla $u Institute of Experimental Medicine, Czech Academy of Sciences, 14220 Prague, Czech Republic $u Department of Neuroscience, Second Faculty of Medicine, Charles University, 15006 Prague, Czech Republic $1 https://orcid.org/0000000246449212 $7 xx0068971
- 700 1_
- $a Machová Urdzíková, Lucia $u Institute of Experimental Medicine, Czech Academy of Sciences, 14220 Prague, Czech Republic $u Department of Neuroscience, Second Faculty of Medicine, Charles University, 15006 Prague, Czech Republic $1 https://orcid.org/0000000176225837 $7 xx0136406
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 24, č. 4 (2023)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36835210 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425141132 $b ABA008
- 999 __
- $a ok $b bmc $g 1924690 $s 1190383
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 24 $c 4 $e 20230214 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- GRA __
- $a MC-PC-16050 $p Medical Research Council $2 United Kingdom
- GRA __
- $a MR/S011110/1 $p Medical Research Council $2 United Kingdom
- LZP __
- $a Pubmed-20230418